Market Overview

Morning Market Movers

Share:
Related OMED
15 Stocks With The Highest Forecast Sales Growth
10 Stocks With Lowest Close In Three Weeks
Related CELG
Celgene Higher Off Positive Phase II Sunbeam Trial Of Oral Ozanimod
Couldn't Make It To Leerink's Global Healthcare Conference? Here Are The Highlights From Day One
FDA OKs expanded use of Celgene's Revlimid (Seeking Alpha)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (CELG + CNAT)

View Comments and Join the Discussion!